Catinazzo Thomas
CIK 1818261
Transactions on file
28
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-30 | 2026-07-28 | RLAY Relay Therapeutics, Inc. | Chief Financial Officer | Sale | 1,459 | $27.2K | +4.5% | open → |
| 2026-07-08 | 2026-07-06 | RLAY Relay Therapeutics, Inc. | Chief Financial Officer | Sale | 17,717 | $331.1K | +4.1% | open → |
| 2026-06-24 | 2026-06-22 | RLAY Relay Therapeutics, Inc. | Chief Financial Officer | Sale | 51,560 | $875.0K | +14.6% | open → |
| 2026-06-24 | 2026-06-22 | RLAY Relay Therapeutics, Inc. | Chief Financial Officer | Exer. | 51,560 | $229.4K | +337.1% | open → |
| 2026-06-24 | 2026-06-22 | RLAY Relay Therapeutics, Inc. | Chief Financial Officer | Sale | 61,563 | $1.04M | +14.6% | open → |
| 2026-06-24 | 2026-06-22 | RLAY Relay Therapeutics, Inc. | Chief Financial Officer | Exer. | 61,563 | $321.4K | +272.6% | open → |
| 2026-06-24 | 2026-06-22 | RLAY Relay Therapeutics, Inc. | Chief Financial Officer | Sale | 56,323 | $955.8K | +14.6% | open → |
| 2026-06-24 | 2026-06-22 | RLAY Relay Therapeutics, Inc. | Chief Financial Officer | Exer. | 56,323 | $283.9K | +285.9% | open → |
| 2026-06-24 | 2026-06-22 | RLAY Relay Therapeutics, Inc. | Chief Financial Officer | Sale | 17,717 | $301.4K | +14.3% | open → |
| 2026-05-14 | 2026-05-14 | RLAY Relay Therapeutics, Inc. | Chief Financial Officer | Sale | 17,717 | $227.8K | +51.2% | open → |
| 2026-04-09 | 2026-04-09 | RLAY Relay Therapeutics, Inc. | Chief Financial Officer | Sale | 1,800 | $27.0K | +29.7% | open → |
| 2026-04-09 | 2026-04-09 | RLAY Relay Therapeutics, Inc. | Chief Financial Officer | Exer. | 1,800 | $9.4K | +272.6% | open → |
| 2026-04-09 | 2026-04-07 | RLAY Relay Therapeutics, Inc. | Chief Financial Officer | Sale | 17,717 | $230.5K | +49.5% | open → |
| 2025-01-30 | 2025-01-28 | RLAY Relay Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 2,283 | $10.6K | +320.1% | open → |
| 2025-01-30 | 2025-01-28 | RLAY Relay Therapeutics, Inc. | Officer Chief Financial Officer | Grant | 139,141 | $0.00 | — | open → |
| 2025-01-30 | 2025-01-29 | RLAY Relay Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 2,109 | $9.6K | +327.5% | open → |
| 2025-01-30 | 2025-01-30 | RLAY Relay Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 20,791 | $91.9K | +340.0% | open → |
| 2025-01-30 | 2025-01-28 | RLAY Relay Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 33,753 | $156.3K | +320.1% | open → |
| 2025-03-31 | 2025-03-27 | RLAY Relay Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 298 | $846.32 | +584.9% | open → |
| 2025-03-31 | 2025-03-27 | RLAY Relay Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 4,566 | $13.0K | +584.9% | open → |
| 2025-04-30 | 2025-04-29 | RLAY Relay Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 3,558 | $11.5K | +502.2% | open → |
| 2025-04-30 | 2025-04-28 | RLAY Relay Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 1,709 | $5.4K | +513.6% | open → |
| 2025-04-30 | 2025-04-28 | RLAY Relay Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 981 | $3.1K | +513.6% | open → |
| 2025-04-30 | 2025-04-30 | RLAY Relay Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 12,943 | $38.8K | +548.3% | open → |
| 2026-04-30 | 2026-04-28 | RLAY Relay Therapeutics, Inc. | Chief Financial Officer | Sale | 972 | $14.4K | +31.5% | open → |
| 2025-10-30 | 2025-10-28 | RLAY Relay Therapeutics, Inc. | Chief Financial Officer | Sale | 21,664 | $157.9K | +166.8% | open → |
| 2025-07-30 | 2025-07-29 | RLAY Relay Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 18,380 | $67.6K | +428.5% | open → |
| 2025-07-30 | 2025-07-28 | RLAY Relay Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 1,701 | $6.4K | +420.1% | open → |
